Navigation Links
GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
Date:1/3/2008

sk Factors' in the Business and Prospects in the company's Annual Report on Form 20-F for 2006.

Theravance Forward-Looking Statements

This press release contains certain "forward-looking" statements as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, statements relating to goals, plans, objectives and future events. Theravance intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Examples of such statements include statements relating to the goals, timing and expected results of clinical and preclinical studies, statements regarding the potential benefits and mechanisms of action of drug candidates, statements concerning the goals and timing of seeking regulatory approval of our product candidates, the enabling capabilities of Theravance's approach to drug discovery and its proprietary insights, statements concerning expectations for product candidates through development and commercialization and projections of revenue and other financial items. These statements are based on the current estimates and assumptions of the management of Theravance as of the date of this press release and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that may cause the actual results of Theravance to be materially different from those reflected in its forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others, the potential that results of clinical or preclinical studies indicate product candidates are unsafe, ineffective, inferior or not superior, and delays or failure to achieve regulatory approvals and risks of collaborating with third parties to develop and commercialize products. These a
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
2. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
3. GlaxoSmithKline Accelerates Review of Exelixis XL880
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
7. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
8. FASgen Announces a New Discovery in Obesity Research
9. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
10. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
11. FASgen Announces New Discovery for Treatment of Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- The board of directors of VirtualScopics, Inc. (NASDAQ: ... imaging solutions, today announced that James Groff , ... Mr. Groff has held the role of acting chief ... January 2006 as an accounting manager and was promoted ... board of VirtualScopics asked Jim to assume the role ...
(Date:8/21/2014)... HOUSTON, Aug. 21, 2014  Cyberonics, Inc. (NASDAQ: ... 25, 2014.  Quarterly highlights 1   ... compared to the first quarter of fiscal 2014, and other ... million, an increase of 6.8%; , Strong international net ... constant currency basis; , U.S. net product sales reached ...
(Date:8/20/2014)... , Aug. 20, 2014 Northstar ... announced that after months of hard work from ... the new Snorenz formulation and package design.  The ... and B-6 back into the product due to ... longer lasting effects.  Snorenz Nighttime will also include ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2
... Ala., Nov. 19 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ... 5,000,000 shares of its common stock at $9.75 per share, ... the shares are being offered by BioCryst pursuant to an ... Exchange Commission. BioCryst has also granted the underwriters a ...
... , TAINAN, ... global,supplier of active pharmaceutical ingredients (APIs), announced that ... Certification from,SafeBridge(R) Consultants, Inc. The Certification confirms ScinoPharm,s,competency ... active,pharmaceutical ingredients (APIs), and applies to specific laboratories ...
Cached Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2
(Date:8/21/2014)... News) -- Being born at a low birth weight puts ... new study suggests. The findings may partly explain high ... high prevalence of low birth weight, the researchers added. ... those with a low birth weight were 13 percent more ... normal birth weight. The risk of diabetes was 40 percent ...
(Date:8/21/2014)... 21, 2014 The W. Montague ... and a national voice in the elimination of ... disparities during the 112th National Medical Association’s (NMA) ... included: , John Ruffin, Ph.D, former Director of ... Disparities, whose life-long career and innovations have had ...
(Date:8/21/2014)... WA (PRWEB) August 21, 2014 ... Mulanax at Eastlake Chiropractic and Massage Center ... the Center’s growing team. Rina Lang, LMP and ... a wide range of massage techniques, and have developed ... settings. This is particularly important in a clinical ...
(Date:8/21/2014)... SAN FRANCISCO Aug. 21, 2014 Researchers in ... for congenital cataracts can quickly and accurately diagnose a ... to a study published online today in ... of Ophthalmology. Using a single test, doctors were ... based on their mutations reducing the time and money ...
(Date:8/21/2014)... August 21, 2014 The world wound ... billion in 2014 and reach USD 18.3 billion by ... period. The drivers of such growth include governments’ contribution ... and diabetic population, and surging ageing population. However, the ... wound care products. Region-wise, North America leads the global ...
Breaking Medicine News(10 mins):Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 3Health News:New DNA test for diagnosing diseases linked to childhood blindness 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3
... Home Workers in PA, MI, IL, FL, OH, MD, WI, WA Join Forces ... Private Equity ... Buyout, WASHINGTON, Oct. 3 ... workers union today,is launching a multi-state grassroots campaign calling on global buyout,giant the ...
... quit, researchers say , WEDNESDAY, Oct. 3 (HealthDay News) ... linked to nicotine dependence and to the anxiety and ... Scripps Research Institute in La Jolla, Calif., said the ... smokers kick the habit. , In rats, chronic nicotine ...
... 3 The following is a,statement of William ... President Bush today let down America,s children and ... legislation that would,increase the federal cigarette tax by ... Children,s Health Insurance Program (SCHIP). The President has ...
... Conn., Oct. 3 ,Unilens Vision Inc. (OTC Bulletin Board: ... that Eschenbach Optik has been named,the exclusive worldwide distributor ... Inc. will serve as the exclusive distributor,for North and ... be the,exclusive distributor in the rest of the world. ...
... and Revitalization, ORLANDO, Fla., Oct. 3 ... PRZ ), one of the nation,s leading providers,of ... issued,the following corporate update detailing recent developments that ... refined long term,growth strategy. Specifically, Lubinsky stated: ...
... Education Campaign Urges Enrollment, LOS ANGELES, Oct. 3 ... of clinical trials are being conducted to seek a,treatment, ... potentially fatal,autoimmune disease that affects more than 1.5 million ... key question that clinical trials answer is, "Will this ...
Cached Medicine News:Health News:SEIU Launches Multi-State Grassroots Campaign Calling on the Carlyle Group to Put Care Above Profits in Buyout of Nation's Largest Nursing Home Chain 2Health News:Rat Study Gets at Root of Nicotine Addiction 2Health News:President's Veto of Bill to Increase Cigarette Tax, Fund SCHIP Benefits Big Tobacco at Expense of America's Kids 2Health News:Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens 2Health News:Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens 3Health News:PainCare Reports on Key Corporate Developments 2Health News:PainCare Reports on Key Corporate Developments 3Health News:PainCare Reports on Key Corporate Developments 4Health News:PainCare Reports on Key Corporate Developments 5Health News:Clinical Trials for Lupus Underway After Decades of Drought 2
... Reichert TONO-PEN AVIA tonometer is an ... readings that correlate strongly with Goldmann ... ergonomic design and advanced electronic measurement ... fast and accurate IOP measurements with ...
... Delivery System is a ... to assemble brachytherapy seeds, ... into seed trains of ... variable seed to seed ...
... from innovative research in materials and technologies ... the aerospace and automotive industry, the high- ... footwear and textile industry. , ,This know-how ... Carrera sunglasses collection to create unique and ...
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Medicine Products: